Clinical Tools, Inc — Department of Health and Human Services SBIR Phase I: NIDA
Clinical Tools, Inc — SBIR Phase I award from Department of Health and Human Services.
- Amount
- $223,315
- Agency
- Department of Health and Human Services · National Institutes of Health
- Program / Phase
- SBIR · Phase I
- Topic
- NIDA
- Solicitation
- PA18-574
- NAICS
- —
- Place of performance
- NC
- Period
- 2019-09-30 → 2020-03-31
Description
PROJECT DESCRIPTIONCase based Skills Training for Health Professionals to DecreaseVaping Behavior in Adolescents and Young Adults Vaping and e cigarette useespecially among today s youththreaten to bring back the scourge of addiction to nicotine and introduce a novel indiscreet means to use cannabisFromtorates of e cigarette use by high school students almost doubled toinand in middle school studentsthe rate increased toinOverinhigh school seniors reported past year use of a vaping device inand almostinvape cannabisOverof young adults have used e cigarettesplacing them at risk for a lifetime of addiction to nicotineYet health care providers lack the skillstrainingand resources to reverse these trendsOur Clinical Encounters platform provides a framework to support clinically relevant learning based on challenging scenariosdecision makingstructured feedbackand patient focused complementary resourcesIn the proposed Clinical EncountersVaping experience the health professional will build key clinical skills related to vaping including the deployment of motivational interviewing and ScreeningBrief Interventionand Referral to TreatmentSBIRTskillsA patient centered approach builds a strong collaborative relationship by emphasizing dialoguepatient relevancetailoring an intervention to the patient s needsand the proper use of integrated resources and guides for parentsadolescents and young adultsHigh availability and adherence to rigorous CME standards enhance learner acceptanceThe training will be availableand usable on multiple devicese gphonetabletweb browserand in several different formats such as HTMLPDFePubMobiand audioIt will provide continuing education creditsuch as Category I Continuing Medical EducationCMEfor physicians and be free of biasas we have never accepted funds from pharma and device industry and do not engage consultants with similar tiesClinical Tools has successfully met similar challenges in the past and has the leadershipstaffand established patient centered training framework to quickly and effectively address this need for trainingPhase I will demonstrate feasibility by completing milestones and deliverables associated withspecific aimsAimwill focus on needpreferenceandampproduct analyses to guide curriculum and case designBarriers and challenges to incorporating screening and intervention will also be investigatedSurveys and semistructured interviews with providersexperts and Consultant team will occurAimwill develop a curriculum plan and a limited prototype vaping training module withcasesThe prototype will be usability tested in Aimto guide revisions of the prototype and curriculum plan that will be delivered in Aimalongside a Phase I Final Report summarizing the above and a Phase II III Randamp D Plan PUBLIC HEALTH RELEVANCE STATEMENT E cigarette use and vaping of nicotine and cannabis among today s youth are reversing impressive public health gains from the decreased use of tobacco productsWith proper skills and resourceshealthcare providers can work with parentsadolescentsand young adults to reverse this trendyet such a comprehensive solution does not existOur proposed intervention enhances the skills of health care professionals by providingcase based training and skills development for vaping detectionassessmentand interventionpatient focused communication skills in discussing the topic with adolescents and young adultsandcomplementary educational materials for young adultsadolescentsand their parents guardiansProviders can then fully participate in efforts to protect today s youth from a life long addiction to nicotine and the health consequences